# Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

> **NCT04018170** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 102 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Study drug
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04018170
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2019-12-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04018170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04018170, "Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04018170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*